期刊文献+

氯吡格雷停药后存在的血小板功能反跳现象 被引量:1

The Phenomena of Platelet Function Rebound after Clopidogrel Withdrawal
下载PDF
导出
摘要 对于急性冠状动脉综合征患者的治疗,除非有高出血风险,氯吡格雷应联合阿司匹林使用至少1年。但有部分患者停用氯吡格雷后发生的心血管不良事件,一些研究认为此现象与停用氯吡格雷后血小板功能反跳有关。在此对停用氯吡格雷后血小板聚集率增加的定义,血小板功能反跳现象与血小板聚集能力、炎性因子等之间的关系及延长使用或逐渐停用氯吡格雷能否预防此反跳现象的发生予以综述。 Clopidogrel combined with aspirin should be used at least 1 year in patient with acute coronary syndrome unless there is high risk of bleeding.However,some research suggest that the adverse cardiovascular event happened after clopidogrel withdrawal have some connection with platelet function rebound.Here is to review the definition of enhancive platelet aggregation after clopidogrel withdrawal,the relationship between rebound phenomena and platelet aggregation,and inflammation factor;and if prolonging or tapered withdrawl of clopidogrel can solve the problem.
出处 《医学综述》 2011年第22期3467-3470,共4页 Medical Recapitulate
关键词 氯吡格雷停药 心血管不良事件 血小板功能 反跳现象 Clopidogrel withdrawal Adverse cardiovascular event Platelet function Rebound
  • 相关文献

参考文献20

  • 1Anderson JL, Adams CD, Antman EM,et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients With unstable angina/Non-ST-elevation myocardial infarction : a report of the American college of cardiology foundation/American heart association task force on practice guidelines [ J ]. Circulation ,2011,123 ( 18 ) : e426-579.
  • 2Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:data from a large two-institutional cohort study [ J ]. The Lancet,2007,368 ( 9562 ) : 667-678.
  • 3Ho M, Peterson E,Wang L,et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome[ J]. J Am Med Assoc,2008,299(4) :532-539.
  • 4Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors and outcomes of thrombosis after successful implantation of drug eluting stents[ J]. J Am Med Assoc,2005 ,293 :2126-2130.
  • 5Oberhansli M, Puricel S, Togni M, et al. Coronary stent thrombosis : what's new in 20117 [J]. Herz,2011,36(3) :241-253.
  • 6Stephenson JJ, Chang CL, Devecchis WG,et al. Incidence of death and recun'ing acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US [ J ]. Curr Med Res Opin ,2011,27 ( 6 ) : 1079-1087.
  • 7Airoldi F,Colombo A, Morici N, et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment [ J ]. Circulation,2007,116 (6) :745-754.
  • 8Ho PM,Tsai TT, Wang TY,et al. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients:Insights from a large integrated heahhcare delivery system[ J]. Circ Cardiovasc Qual Outcomes,2010,3 (3) :303-308.
  • 9Diehl P, Halscheid C, Olivier C, et al. Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation [ J ]. Clin Res Cardiol, 2011, [ Epub ahead of print].
  • 10Mylotte D, Peace AJ,Tedesco AT,et al. Clopidogrel discontinuation and platelet reactivity following coronary stenting [ J ]. J Thromb Haemost,2011,9( 1 ) :24-32.

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部